Article
ALT-associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas.
The Journal of pathology - 1 Mar 2008
Venturini L, Erdas R, Costa A, Gronchi A, Pilotti S, Zaffaroni N, Daidone Mg
Abstract excerpt
Most cancers maintain telomeres by activating telomerase, but a significant minority, mainly of mesenchymal origin, utilize an alternative lengthening of telomeres (ALT) mechanism. We previously showed the presence of ALT, as detected by ALT-associated promyelocytic leukaemia bodies (APBs) by combined promyelocytic leukaemia immunofluorescence and telomere fluorescence-in situ hybridization, in approximately 25%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
